Sentai Ding

755 total citations
43 papers, 531 citations indexed

About

Sentai Ding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Sentai Ding has authored 43 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Sentai Ding's work include Bladder and Urothelial Cancer Treatments (10 papers), Renal cell carcinoma treatment (6 papers) and Ubiquitin and proteasome pathways (5 papers). Sentai Ding is often cited by papers focused on Bladder and Urothelial Cancer Treatments (10 papers), Renal cell carcinoma treatment (6 papers) and Ubiquitin and proteasome pathways (5 papers). Sentai Ding collaborates with scholars based in China, Japan and United Kingdom. Sentai Ding's co-authors include Jiajü Lü, Kejia Ding, Fei Wu, Dongbin Bi, Zhihong Niu, Zuohui Zhao, Shuai Liu, Koji Nishizawa, Hiroyuki Nishiyama and Shasha Qi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Sentai Ding

42 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sentai Ding China 15 322 123 117 105 96 43 531
Weiwei Li China 14 281 0.9× 96 0.8× 51 0.4× 227 2.2× 106 1.1× 44 631
Akito Hata Japan 11 217 0.7× 160 1.3× 52 0.4× 102 1.0× 82 0.9× 16 516
Huijie Yang China 15 501 1.6× 94 0.8× 111 0.9× 207 2.0× 155 1.6× 40 711
Rong Biaoxue China 16 442 1.4× 220 1.8× 104 0.9× 170 1.6× 138 1.4× 33 755
Woo Song Ha South Korea 10 274 0.9× 54 0.4× 44 0.4× 109 1.0× 72 0.8× 17 417
Laura Calleros Spain 15 283 0.9× 54 0.4× 41 0.4× 93 0.9× 86 0.9× 31 581
Jennifer R. Bethard United States 12 262 0.8× 57 0.5× 62 0.5× 60 0.6× 87 0.9× 24 467
Yanling Chen China 13 297 0.9× 79 0.6× 36 0.3× 137 1.3× 175 1.8× 41 600
Hiromitsu Nagata Japan 12 327 1.0× 69 0.6× 69 0.6× 153 1.5× 99 1.0× 35 666

Countries citing papers authored by Sentai Ding

Since Specialization
Citations

This map shows the geographic impact of Sentai Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sentai Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sentai Ding more than expected).

Fields of papers citing papers by Sentai Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sentai Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sentai Ding. The network helps show where Sentai Ding may publish in the future.

Co-authorship network of co-authors of Sentai Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Sentai Ding. A scholar is included among the top collaborators of Sentai Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sentai Ding. Sentai Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Pengcheng, et al.. (2025). Association between sex steroid hormones and α-klotho: Results from the NHANES 2013-2016 and Mendelian randomization study. Experimental Gerontology. 201. 112699–112699. 1 indexed citations
2.
Wu, Chenrui, et al.. (2024). Uric acid mediates the association between testosterone and α-Klotho among males: results from the NHANES 2013–2016. International Urology and Nephrology. 57(3). 939–946. 1 indexed citations
3.
4.
Ding, Sentai, et al.. (2024). Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder carcinoma: A narrative review. Current Urology. 19(1). 39–42. 2 indexed citations
5.
6.
Li, Kaiwen, Jinhai Fan, Shaogang Wang, et al.. (2023). Final analysis results from a multicenter clinical study of tislelizumab combined with gemcitabine and cisplatin as neoadjuvant therapy in patients with cT2-T4aN0M0 MIBC.. Journal of Clinical Oncology. 41(16_suppl). 4585–4585.
7.
Chen, Tong, Xianlong Wang, Haobo Zhang, et al.. (2022). ICSI outcomes for infertile men with severe or complete asthenozoospermia. Basic and Clinical Andrology. 32(1). 6–6. 9 indexed citations
8.
Tian, Linlin, Bin Qian, Xiaohui Jiang, et al.. (2021). MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients. International Journal of Genomics. 2021. 1–16. 12 indexed citations
9.
Sun, Liang, Jiajü Lü, Sentai Ding, et al.. (2017). HCRP1 regulates proliferation, invasion, and drug resistance via EGFR signaling in prostate cancer. Biomedicine & Pharmacotherapy. 91. 202–207. 7 indexed citations
10.
Wang, Zhiyang, Shuai Liu, Kejia Ding, et al.. (2016). Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells. Tumor Biology. 37(11). 15133–15143. 10 indexed citations
11.
Sun, Liang, Jiajü Lü, Zhihong Niu, et al.. (2015). A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer. PLoS ONE. 10(12). e0144484–e0144484. 29 indexed citations
12.
Ding, Sentai, Zuohui Zhao, Fei Wu, et al.. (2014). Eg5 inhibitor, a novel potent targeted therapy, induces cell apoptosis in renal cell carcinoma. Tumor Biology. 35(8). 7659–7668. 9 indexed citations
13.
Zhao, Zuohui, Fei Wu, Sentai Ding, et al.. (2014). Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma. Tumor Biology. 36(2). 939–951. 39 indexed citations
14.
Wu, Fei, Sentai Ding, & Jiajü Lü. (2013). Truncated ERG proteins affect the aggressiveness of prostate cancer. Medical Hypotheses. 80(4). 490–493. 4 indexed citations
15.
Lü, Jiajü, Kejia Ding, Dongbin Bi, et al.. (2013). The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma. Medical Oncology. 30(1). 476–476. 33 indexed citations
16.
Wu, Fei, et al.. (2013). High Mobility Group Box 1 Protein Is Methylated and Transported to Cytoplasm in Clear Cell Renal Cell Carcinoma. Asian Pacific Journal of Cancer Prevention. 14(10). 5789–5795. 27 indexed citations
17.
Ding, Sentai, Ryoichi Saito, Koji Nishizawa, et al.. (2011). A potent chemotherapeutic strategy in prostate cancer: S-(methoxytrityl)-L-cysteine, a novel Eg5 inhibitor. Asian Journal of Andrology. 13(2). 236–241. 19 indexed citations
18.
Ding, Sentai, Jiajü Lü, Hui Zhang, et al.. (2011). Overexpression of Eg5 predicts unfavorable prognosis in non‐muscle invasive bladder urothelial carcinoma. International Journal of Urology. 18(6). 432–438. 41 indexed citations
19.
Ding, Sentai, et al.. (2009). A novel modification of tunical plication by plaque thinning: long-term results in treating penile curvature of Peyronie’s disease. International Urology and Nephrology. 42(3). 597–602. 6 indexed citations
20.
Matsui, Yoshiyuki, Jun Watanabe, Sentai Ding, et al.. (2009). Dicoumarol enhances doxorubicin‐induced cytotoxicity in p53 wild‐type urothelial cancer cells through p38 activation. British Journal of Urology. 105(4). 558–564. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiwei Li Breakdown of academic impact, for papers by Akito Hata Breakdown of academic impact, for papers by Huijie Yang Breakdown of academic impact, for papers by Rong Biaoxue Breakdown of academic impact, for papers by Woo Song Ha Breakdown of academic impact, for papers by Laura Calleros Breakdown of academic impact, for papers by Jennifer R. Bethard Breakdown of academic impact, for papers by Yanling Chen Breakdown of academic impact, for papers by Hiromitsu Nagata
Rankless by CCL
2026